SAFE-MRI aims to prevent needless mortality from breast cancer by optimizing the use and performance of dedicated breast MRI.
First SAFE-MRI aims at detecting breast cancer early in women that are currently deemed too young for po...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
DPI2015-68442-R
ANALISIS DE IMAGENES INTELIGENTE PARA LOS RETOS EN EL CRIBAD...
138K€
Cerrado
TIN2012-37171-C02-01
IA-BIOBREAST: ANALISIS TEMPORAL Y DETECCION AUTOMATICA DE LE...
33K€
Cerrado
TED2021-130081B-C21
A COMPREHENSIVE COMPUTER-AIDED DIGANOSIS (CAD) SYSTEM BASED...
193K€
Cerrado
CPP2021-008336
Desarrollo de un test para el diagnóstico precoz no invasivo...
491K€
Cerrado
RTC-2015-3287-1
Desarrollo de un algoritmo diagnóstico multimodal incluyendo...
193K€
Cerrado
PLEC2021-007709
ProCanAid - Gemelo digital para la detección, el diagnóstico...
752K€
Cerrado
Información proyecto SAFE-MRI
Duración del proyecto: 61 meses
Fecha Inicio: 2023-04-24
Fecha Fin: 2028-05-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
SAFE-MRI aims to prevent needless mortality from breast cancer by optimizing the use and performance of dedicated breast MRI.
First SAFE-MRI aims at detecting breast cancer early in women that are currently deemed too young for population screening (age 45-50). Early diagnosis of breast cancer in these women will lead to a large gain in DALY’s averted. I will initiate a prospective screening study inviting women to a one-time only abbreviated breast MRI at the age of 45. The primary outcome will be the cancer detection rate per 1000 women actually screened. This will validate abbreviated breast MRI as standalone screening technique. Psycho-social and risk information will be collected from all participants. Cost-effectiveness modelling will be included. 5-year follow-up will be performed in all women up to, and including, the first screening round at the age of 50.
Second SAFE-MRI aims at improving breast MRI by reducing the need for contrast administration. This is a major downside of breast MRI - for women (iv-canulation and a small risk of allergic reactions) and the environment (pollution of surface water). First, I aim to enhance signal changes using a strongly reduced dose of contrast with advanced deep learning (DL). Further studies are tailored at assessment of unenhanced MRI. Particularly, I will validate novel diffusion weighted imaging (DWI) sequences capable of generating high resolution diagnostic images within short scan times using DL-based reconstruction. Furthermore, I will investigate arterial spin labelling (ASL) based breast imaging strategies that show perfusion without the need for contrast administration. Finally, we will combine unenhanced MRI techniques in a general adversarial network to construct synthetic breast MRI images. Repeated reader studies will be conducted to assess image quality and diagnostic value. SAFE-MRI will thus consolidate my leading role in breast imaging and enable me to design the breast screening of the future.